Flexeril and Diprivan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flexeril and Diprivan. Common interactions include sepsis among females and anxiety among males.

The phase IV clinical study analyzes what interactions people who take Flexeril and Diprivan have. It is created by eHealthMe based on reports of 52 people who take Flexeril and Diprivan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

52 people who take Flexeril and Diprivan together, and have interactions are studied.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 36,909 Flexeril users for its effectiveness, alternative drugs and more.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,276 Diprivan users for its effectiveness, alternative drugs and more.

Number of Flexeril and Diprivan reports submitted per year:

Common Flexeril and Diprivan drug interactions by gender *:

female:

Sepsis
Appendicitis
Aptyalism
Asthma
Bone disorder
Bone erosion
Bone fragmentation
Bone pain
Bronchopneumonia
Cellulitis

male:

Anxiety
Depression
Bronchitis
Chronic obstructive pulmonary disease
Colon adenoma
Constipation
Decreased appetite
Device related infection
Dysphagia
Emotional distress

Common Flexeril and Diprivan drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Acute myocardial infarction
Acute respiratory distress syndrome
Anaemia
Blastomycosis
Blood creatinine increased
Bradycardia
Cardiac enzymes increased
Fluid overload
Headache
Hepatic enzyme increased

40-49:

Encephalopathy
Embolism
Oedema peripheral
Colorectal cancer metastatic
Retroperitoneal lymphadenopathy
Venous occlusion
Venous thrombosis
Abdominal distension
Abdominal pain
Device dislocation

50-59:

Nausea
Lumbar spinal stenosis
Platelet count increased
Hypoaesthesia
Rectal haemorrhage
Device failure
Nasal congestion
Scab
Tooth extraction
Hypogammaglobulinaemia

60+:

Chronic kidney disease
Renal failure
Anxiety
Bipolar disorder
Depression
Dyspnoea
Fall
Hyperparathyroidism secondary
Ileus
Nephrogenic anaemia

Common conditions people have *:

Osteoporosis (bones weak and more likely to break): 28 people, 53.85%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 27 people, 51.92%
Pain: 16 people, 30.77%
Thrombocytopenia (decrease of platelets in blood): 12 people, 23.08%
Nausea And Vomiting: 7 people, 13.46%
Nausea (feeling of having an urge to vomit): 7 people, 13.46%
High Blood Pressure: 6 people, 11.54%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 11.54%
Depression: 6 people, 11.54%
Breakthrough Pain: 5 people, 9.62%

* Approximation only. Some reports may have incomplete information.

Do you take Flexeril and Diprivan?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Flexeril (36,909 reports)
Diprivan (6,276 reports)